title: Magnetic resonance of the liver with hepato-specific contrast: initial clinical experience in Brazil.
abstract: The authors report the initial clinical experience of gadoxetic acid as a liver-specific magnetic resonance (MR) imaging contrast mediumin a private clinic in Brasil. This substance, which was recently approved for clinical use in the country, shows specific uptake by the hepatocytes, reaching a concentration peak around 10-20 minutes post-injection. Among the main indications for the use of this contrast medium in MR examinations are: diagnosis of hepatocellular carcinoma, detection and treatment planning of liver metastases, and the differentiation between focal nodular hyperplasia and hepatocellular adenoma.
authors.affiliation: CDPI Clinic, DASA, Rio de Janeiro, Brazil. lkayat@gmail.com
authors.forename: Leonardo Kayat
authors.initials: LK
authors.lastname: Bittencourt
authors.forename: Daniel
authors.initials: D
authors.lastname: Hausmann
authors.forename: Emerson Leandro
authors.initials: EL
authors.lastname: Gasparetto
authors.forename: Romeu Côrtes
authors.initials: RC
authors.lastname: Domingues
mesh_terms: D001938:Brazil; D003287:Contrast Media; D019786:Gadolinium DTPA; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging / Q000379:methods*
chemical_list: D003287:Contrast Media; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA